The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro
The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro.
The Journal of Steroid Biochemistry and Molecular Biology.
2018,
178,
263-271,
ISSN: 0960-0760,
PMID: 29307714,